St. Charles-Borromee, Canada Clinical Trials

A listing of St. Charles-Borromee, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 52 clinical trials
Savonix Inc-Alzheimer’s Disease Discovery

This study is looking for adults over the age of 22. This is an online cognitive study.Click the link below for more information:https://www.assiststudy.org/

Online studies
Accepts healthy volunteers
Online Study Center
(online study) Contact site
  • 630 views
  • 23 Sep, 2022
  • 1 location
  • Online study
Web-Based Assessment Validation and Engagement Study

This study is looking for people who are over the age of 55 and have mild cognitive impairment or dementia. The study is also looking for people with normal cognition, as a comparison. The study is investigating a new computerized assessment.

Online studies
Accepts healthy volunteers
cognitive assessment
mild cognitive impairment
cognitive impairment
Online Study Center
(online study) Contact site
  • 1713 views
  • 23 Sep, 2022
  • 1 location
  • Online study
Promoting Reengagement in Daily Meaningful Activity Intervention for adults with mild cognitive impairment and their caregivers

The PRIMA project is design to help persons with mild cognitive impairment to help them to improve their engagement in personally meaningful activity and improve their overall quality of life with their family caregivers support. The goal of PRIMA project is to increase persons with mild cognitive impairment’s engagement in …

Online studies
Accepts healthy volunteers
Online Study Center
(online study) Contact site
  • 371 views
  • 23 Sep, 2022
  • 1 location
  • Online study
Objective, Passive Assessment of LRRK2 Carriers (OPAL)

This study is currently only open to active participants in the University of Rochester’s VALOR-PD study. The goal of this project is to identify objective, sensitive, and convenient measures for assessing early signs of Parkinson's disease in an at-risk population at home. We will do so by using a wireless …

Online studies
movement disorder
University of Rochester
(online study) Contact site
  • 64 views
  • 12 May, 2022
  • 1 location
  • Online study
A Phase 3b, Randomized, Double-blind, Placebo-controlled, 24-week Study to Assess the Efficacy and Safety of Fezolinetant in Menopausal Women Suffering From Moderate to Severe Vasomotor Symptoms (Hot Flashes) and Considered Unsuitable for Hormone Replacement Therapy (Daylight)

This study is for women in menopause who have moderate to severe hot flashes. It is for women who are unable to use hormone replacement therapy (HRT). Menopause, a normal part of life, is the time after a woman's last period. Hot flashes often occur during menopause. They can disrupt …

Site CA15011
 (0.8 away) Contact site
  • 30 views
  • 18 Sep, 2022
  • +88 other locations
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib Administered Once Daily for 52 Weeks in Subjects With Non-Cystic Fibrosis Bronchiectasis - The ASPEN Study (ASPEN)

The primary objective of this study is to evaluate the effect of brensocatib at 10 mg and 25 mg compared with placebo on the rate of pulmonary exacerbations (PEs) over the 52-week treatment period.

CAN003
 (0.8 away) Contact site
  • 123 views
  • 20 Sep, 2022
  • +329 other locations
Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level (MATINEE)

This is a multi-center, randomized, placebo-controlled, double-blind, parallel group study designed to confirm the benefits of mepolizumab treatment on moderate or severe exacerbations in chronic obstructive pulmonary disease (COPD) participants given as an add on to their optimized maintenance COPD therapy. The maximum duration of participant participation is approximately 109 …

antibiotics
albuterol
eosinophil count
muscarinic antagonists
cigarette smoke
GSK Investigational Site
 (0.8 away) Contact site
  • 552 views
  • 23 Apr, 2022
  • +221 other locations
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Phase 2a Study to Explore the Efficacy and Safety of Tezepelumab in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) (COURSE) (COURSE)

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2a Study to Explore the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

ct scan
bronchodilator
copd exacerbation
severe chronic obstructive pulmonary disease
Research Site
 (0.8 away) Contact site
  • 415 views
  • 17 Sep, 2022
  • +74 other locations
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

The main purpose of this study is to evaluate the efficacy of mRNA 1647 vaccine in CMV-seronegative female participants and to evaluate the safety and reactogenicity of mRNA-1647 vaccine in all participants.

Accepts healthy volunteers
Diex Recherche - Joilette - HyperCore - PPDS
 (0.8 away) Contact site
  • 97 views
  • 17 Sep, 2022
  • +125 other locations
A Randomized, Double-blind, Placebo-controlled Phase 3 Efficacy Study of an Ad26.RSV.preF-based Vaccine in the Prevention of Lower Respiratory Tract Disease Caused by RSV in Adults Aged 60 Years and Older (EVERGREEN)

The study will enroll up to 27,500 participants in order to demonstrate the efficacy of the active Ad26.RSV.preF-based study vaccine in the prevention of Reverse Transcription Polymerase Chain Reaction (RT-PCR) confirmed Respiratory Syncytial Virus (RSV)-mediated Lower Respiratory Tract Disease (LRTD) when compared to placebo in adults aged 60 years and …

Accepts healthy volunteers
DIEX Recherche Joliette Inc.
 (0.8 away) Contact site
  • 46 views
  • 17 Sep, 2022
  • +258 other locations